Medical Doctor Program year 2025 Reported 2020–2025 Source: CMS Open Payments, 2026 publication

Braiden Heaps

Orthopaedic Surgery Gilbert, AZ Medical Doctor

NPI 1245625102 CMS profile 8138470

3420 S Mercy Rd Ste 200, Gilbert, AZ 85297

Open in the dashboard

General payments

$96,449

127 records reported · program years 2020–2025

Research payments

$0

Paid to them · None reported · program years 2020–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Braiden Heaps of Gilbert, AZ is reported in the CMS Open Payments database as having received $96,449 across 127 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 92nd percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $23,792 23
2024 General $17,452 14
2023 General $1,403 15
2022 General $4,415 35
2021 General $18,827 26
2020 General $30,561 14

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Braiden Heaps
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Braiden Heaps were reported at $23,792. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Braiden Heaps Orthopaedic Surgery median Middle half National median
2019 $0 $644 $140–$2,844 $163
2020 $30,561 $312 $75–$1,860 $114
2021 $18,827 $520 $117–$2,495 $132
2022 $4,415 $598 $128–$2,731 $149
2023 $1,403 $461 $128–$2,264 $160
2024 $17,452 $497 $134–$2,475 $164
2025 $23,792 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2020–2025
  1. Vericel Corporation $41,111 36 payments
  2. Arthrex, Inc. $23,152 34 payments
  3. Micromed Inc $22,597 21 payments
  4. Smith+Nephew, Inc. $4,623 5 payments
  5. ImpactOrtho, Inc. $3,917 18 payments
  6. Stryker Corporation $794 10 payments
  7. Dynasplint Systems Inc. $162 1 payment
  8. Innovation Technologies Inc $63 1 payment
  9. DePuy Synthes Sales Inc. $32 1 payment

Every payment, record by record

What the payments were for General payments · program years 2020–2025
  1. Education $30,530 26 payments
  2. Grant $20,000 1 payment
  3. Compensation for serving as faculty or as a speaker for a medical education program $19,865 5 payments
  4. Honoraria $11,575 5 payments
  5. Travel and Lodging $5,193 18 payments
  6. Consulting Fee $4,720 2 payments
  7. Food and Beverage $4,566 70 payments
Products named General payments · program years 2020–2025
  1. MACI $41,111 36 payments
  2. CINCHLOCK $333 4 payments
  3. Q-FIX Hip $165 2 payments
  4. Dynasplint $162 1 payment
  5. ARTHROPLASTY IMPLANTS ANATOMIC TOTAL SHOULDER ECLIPSE $148 1 payment
  6. NANO TACT FLEX $142 1 payment
  7. NA $141 1 payment
  8. Q-FIX Shoulder $141 1 payment
  9. Latarjet System $141 1 payment
  10. NOVOSTITCH PRO $141 1 payment
  11. Other $587 10 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

192

Median for Orthopedic Surgery: 203

Drug cost

$808

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone Hcl Generic 41 $354
Meloxicam Generic 68 $156
Tramadol Hcl Generic 26 $111
Ondansetron Hcl Generic 31 $109
Prednisone Generic 26 $78

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 76 billing codes

Paid by Medicare

$107,334

Of which drugs: $8,023

Medicare patients

206

Average age 73

Services billed

7,849

118 women, 88 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 73%
Diabetes 27%
Chronic kidney disease 27%
Ischemic heart disease 25%
Depression 23%
Atrial fibrillation 18%
Cancer 18%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, methylprednisolone acetate, 1 mg J1010 Office 73 5,125 $510
Injection, methylprednisolone acetate, 40 mg J1030 Office 25 36 $171

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

127 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Arizona

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record